FDA Inspection 712920 — Baxalta Belgium Manufacturing SA
The FDA completed an inspection of Baxalta Belgium Manufacturing SA on Jan 21, 2011 in Lessines. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Biologics.
Inspection details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jan 21, 2011
- Fiscal Year
- 2011
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Lessines (Belgium)